About this trial
The purpose of this study is to evaluate the clinical and cost-effectiveness of an intelligent therapy based on digital cognitive behavioral therapy for insomnia disorders
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
(1) Clinical diagnosis of insomnia disorder; (2) Cooperate to complete the questionnaire surveys.
Disqualifiers
(1) Current use of central nervous system stimulants; (2) Use of analgesics, theophylline preparations, steroid medications; (3) Alcohol abuse or regular alcohol intake; (4) Diagnosis of other sleep disorders (e.g., obstructive sleep apnea, rapid eye movement sleep behavior disorder, restless legs syndrome) ; (5) Sleep disorders secondary to organic diseases (e.g., epilepsy, diabetes, renal failure).
Trial design
Parallel
Treatments tested in this trial
Intelligent Diagnostic and Treatment Model
Other interventionIntelligent CBTI
Traditional treatment
Drugsleep drug treatment
Treatment groups
Trial outcomes
Primary outcomes
the score of Insomnia Severity Index scale
The total score ranges from 0 to 28, and a higher score indicates higher levels of insomnia severity. A score of 8 or greater is the cut point for clinically possible insomnia
Secondary outcomes
Change in total sleep time (TST) measured by sleep diary
Change in sleep onset latency (SOL) measured by sleep diary
Change in wake after sleep onset (WASO) measured by sleep diary
Change in sleep efficiency (SE) measured by sleep diary
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Zan Wang
Lead sponsor
The First Hospital of Jilin University
Sponsor institution